Either you have JavaScript disabled or your browser does not support Javascript . To work properly, this page requires JavaScript to be enabled.
How to enable JavaScript in your browser?

ZyCoV D

X
Drug Profile

ZyCoV D

Alternative Names: Coronavirus DNA vaccine - Zydus Cadila; Novel corona virus-2019-nCov vaccine; Plasmid DNA vaccine - Zydus Cadila

Latest Information Update: 07 Jan 2022

Price : $50 *
  • Adis is an information provider. We do not sell or distribute actual drugs.
  • Final gross price and currency may vary according to local VAT and billing address.
  • Your purchase entitles you to full access to the information contained in our drug profile at the time of purchase.
  • A link to download a PDF version of the drug profile will be included in your email receipt.

At a glance

  • Originator Zydus Cadila
  • Class COVID-19 vaccines; DNA vaccines; Viral vaccines
  • Mechanism of Action Immunostimulants
  • Orphan Drug Status

    Orphan designation is assigned by a regulatory body to encourage companies to develop drugs for rare diseases.

    No
  • New Molecular Entity No
  • Available For Licensing Yes

Highest Development Phases

  • Registered COVID 2019 infections

Most Recent Events

  • 05 Jan 2022 ZyCoV D receives Emergency Use Authorisation (EUA) from the Drug Controller General of India (DCGI) for COVID-2019 infections (Prevention, In adolescents) in India, prior to January 2022
  • 23 Aug 2021 Registered for COVID-2019 infections (Prevention, In adults, In adolescents, In the elderly) in India (Intradermal)
  • 23 Aug 2021 ZyCoV D receives Emergency Use Authorisation (EUA) from the Drug Controller General of India (DCGI) for COVID-2019 infections (Prevention) in India

You need to be a logged in or subscribed to view this content Request demo

If your organization or you do not have a subscription, try one of the following:
  • Contacting your organization’s admin about adding this content to your AdisInsight subscription
  • Buying a PDF version of any individual profile
  • Request a free trial
If your organization has a subscription, there are several access options, even while working remotely:
  • Working within your organization’s network
  • with username/password or try to via your institution
  • Persisted access using your organization’s identifier stored in your user browser for 90 days
Back to top